3,4-Di-substituted cyclobutene1,2-diones as cxc-chemokine receptor ligands

Details for Australian Patent Application No. 2010212484 (hide)

Owner Pharmacopeia, LLC Schering Corporation

Inventors Taveras, Arthur G.; Aki, Cynthia J.; Bond, Richard W.; Chao, Jianping; Dwyer, Michael; Ferreira, Johan A.; Chao, Jianhua; Yu, Younong; Baldwin, John J.; Kaiser, Bernd; Li, Ge; Merritt, J. Robert; Nelson, Kingsley H.; Rokosz, Laura L.

Agent Griffith Hack

Pub. Number AU-B-2010212484

Parent 2006203679

Filing date 20 August 2010

Wipo publication date 9 September 2010

Acceptance publication date 12 April 2012

International Classifications

C07C 237/30 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/36 (2006.01)

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/401 (2006.01) - Proline

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61K 31/42 (2006.01) - Oxazoles

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/443 (2006.01)

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

Event Publications

9 September 2010 Application Open to Public Inspection

  Published as AU-B-2010212484

9 September 2010 Complete Application Filed

12 April 2012 Application Accepted

  Published as AU-B-2010212484

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010212485-Industrial Maintainence Solution

2010212483-Electrochemical cell and method of making an electrochemical cell